首页 | 本学科首页   官方微博 | 高级检索  
检索        

肿瘤血管内皮特异性靶向肽GX1在结肠癌与肺癌中显像差异分析
引用本文:惠晓丽,刘惊涛,刘 洋,殷继鹏,方如塘,李 明,吴开春.肿瘤血管内皮特异性靶向肽GX1在结肠癌与肺癌中显像差异分析[J].现代肿瘤医学,2015,0(13):1783-1786.
作者姓名:惠晓丽  刘惊涛  刘 洋  殷继鹏  方如塘  李 明  吴开春
作者单位:1.西安交通大学第一附属医院内分泌科干部病区,陕西 西安 710061;2.中国人民解放军第451医院核医学科,陕西 西安 710054;3.第四军医大学西京消化病医院,肿瘤生物学国家重点实验室,陕西 西安 710032
基金项目:国家自然科学基金重大项目(编号:81090270,81090273);国家科技重大专项“重大新药创制”专题(编号:2009ZX09103-667);国家高技术研究发展计划(863计划)项目(编号:2006AA022103);国家自然科学基金项目(编号:30900704);陕西省科技攻关计划项目(编号:2013K12-09-03);陕西省自然科学基金项目(编号:2014JM2-8184)
摘    要:目的:分析肿瘤血管内皮特异性靶向肽GX1在结肠癌与肺癌中的显像差异,探讨GX1在胃肠道肿瘤早期诊治的应用价值。方法:构建荷人结肠癌、肺癌移植瘤裸鼠模型,99Tcm直接法制备99Tcm-GX1,经尾静脉分别注入荷人结肠癌、肺癌小鼠体内,SPECT显像连续追踪24h,观察99Tcm-GX1在结肠癌与肺癌中显像差异,计算机勾划肿瘤及心脏感兴趣区,比较两组T/NT比值差异。结果:99Tcm直接法标记GX1,所得标记率在90%以上,无需纯化,比活度大于200Ci/mmol,满足显像要求。结肠癌组荷瘤小鼠自8h起右后肢背侧肿瘤部位即可见放射性浓聚,并高于心血池本底,T/NT比值>1,18h显影最清晰,随时间延长T/NT比值总体呈递增趋势;肺癌组荷瘤小鼠8h右后肢背侧肿瘤部位无明显显影, 自12h起肿瘤部位开始出现放射性浓聚,并高于心血池本底,18h显影最清晰,T/NT比值随时间延长亦呈递增趋势。比较两组T/NT比值,自8h至24h,结肠癌组比值持续高于肺癌组。结论:GX1可靶向到结肠癌与肺癌荷瘤小鼠的肿瘤组织,并具有肿瘤标志物的影像学特征,与肺癌相比,GX1在结肠癌成像中具有更高的灵敏度、更高的体内肿瘤组织滞留率和更高的T/NT比率。结合早期胃癌中研究结果,GX1在胃肠道肿瘤早期时相探测方面较肺癌具有更多优势。

关 键 词:肿瘤  血管靶向  结肠癌  肺癌  GX1

Imaging variation analysis of tumor vasculature homing peptide GX1 in colon cancer and lung cancer
Hui Xiaoli,Liu Jingtao,Liu Yang,Yin Jipeng,Fang Rutang,Li Ming,Wu Kaichun.Imaging variation analysis of tumor vasculature homing peptide GX1 in colon cancer and lung cancer[J].Journal of Modern Oncology,2015,0(13):1783-1786.
Authors:Hui Xiaoli  Liu Jingtao  Liu Yang  Yin Jipeng  Fang Rutang  Li Ming  Wu Kaichun
Institution:1.Cadre Ward of Department of Endocrinology,First Affiliated Hospital of Xi'an Jiaotong University,Shaanxi Xi'an 710061,China;2.Department of Nuclear Medicine,No.451 Hospital of PLA,Shaanxi Xi'an 710054,China;3.Xijing Hospital of Digestive Diseases & State Key Laboratory of Cancer Biology,Fourth Military Medical University,Shaanxi Xi'an 710032,China.
Abstract:Objective:To analyze the imaging variation of tumor vasculature homing peptide GX1 in colon cancer and lung cancer.Methods:99Tcm-GX1 was prepared by labeling GX1 peptide acquired by chemosynthesis with 99TcmO4-using direct labeling method.ECT imaging of nude mice bearing tumor xenografts of human colon cancer and lung cancer injected with 99Tcm-GX1 was performed to analyze the imaging variation.T/NT ratios were calculated by comparing the radioactivity in tumor and heart.Results:99Tcm-GX1 was acquired with high label radiolabeling efficiency exceeding 90%,high specific activity beyond 200Ci/mmol,which confirmed the qualification of 99Tcm-GX1 for ECT imaging.The tumor on the right flank can be visualized from 8h in colon cancer group with a increasing trend including higher radioactivity than heart and T/NT ratio greater than 1 on the whole.In lung cancer group,there was obvious radioactivity visualized in the tumor on the right flank from 12h compared with the imaging at 8h and the increasing trend including higher radioactivity than heart and T/NT ratio greater than 1 was showed on the whole.The most clearly visualized imaging appeared at 18h in both groups.Continuous higher T/NT ratios between tumor and heart were observed in colon cancer group compared to that of lung cancer group from 8h to 24h.Conclusion:GX1 owned the imaging feature of tumor marker by specific targeting to colon cancer and lung cancer tissue in tumor-bearing nude mice.Compared with that of lung cancer,ECT imaging in colon cancer with GX1 peptide showed higher sensitivity,tumor retention,and T/NT ratios.Combing the former results in gastric cancer,the superiority of GX1 peptide for early detection in gastroenteric tumor was fully confirmed.
Keywords:tumor  vasculature targeting  colon cancer  lung cancer  GX1
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号